Bekoz, H. Et Al. 2017. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience. ANNALS OF ONCOLOGY , vol.28, no.10 , 2496-2502.

Bekoz, H., Karadurmus, N., Paydas, S., Turker, A., Toptas, T., Tuglular, T. F., ... Sonmez, M.(2017). Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience. ANNALS OF ONCOLOGY , vol.28, no.10, 2496-2502.

Bekoz, H. Et Al. "Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience," ANNALS OF ONCOLOGY , vol.28, no.10, 2496-2502, 2017

Bekoz, H. Et Al. "Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience." ANNALS OF ONCOLOGY , vol.28, no.10, pp.2496-2502, 2017

Bekoz, H. Et Al. (2017) . "Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience." ANNALS OF ONCOLOGY , vol.28, no.10, pp.2496-2502.

@article{article, author={H. Bekoz Et Al. }, title={Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience}, journal={ANNALS OF ONCOLOGY}, year=2017, pages={2496-2502} }